The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment.The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
In a remarkable milestone for India’s medical device industry, a next-generation heart stent developed in India has received major global recognition, highlighting the country’s growing innovation and self-reliance in advanced cardiovascular technologies.The indigenous stent, designed and manufactured under the ‘Make in India’ initiative, has been
In a landmark move strengthening its international presence, Narayana Health, one of India’s largest and most respected healthcare providers, has announced the acquisition of UK-based Practice Plus Group (PPG), marking a major milestone in its global expansion strategy.The acquisition, estimated at £160 million (approximately ₹1,700
The Government of Mizoram has launched a statewide ‘Tobacco-Free Youth’ campaign aimed at reducing tobacco consumption among school and college students, reinforcing its commitment to building a healthier, smoke-free generation.The campaign, spearheaded by the State Tobacco Control Cell (STCC) under the National Tobacco Control Programme
The Delhi High Court has upheld the Food Safety and Standards Authority of India (FSSAI)’s regulatory action against a company for misleading labeling and marketing of an ‘ORS’-branded product, emphasizing that public health must take precedence over commercial interests.The court ruled that the product in
